Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Non Operating Income (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Non Operating Income data on record, last reported at -$5.0 million in Q4 2025.

  • For Q4 2025, Non Operating Income changed N/A year-over-year to -$5.0 million; the TTM value through Dec 2025 reached $25.0 million, changed N/A, while the annual FY2025 figure was $33.0 million, 31.25% down from the prior year.
  • Non Operating Income reached -$5.0 million in Q4 2025 per RCUS's latest filing, down from $7.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $13.0 million in Q2 2024 and bottomed at -$5.0 million in Q4 2025.
  • Average Non Operating Income over 5 years is $5.8 million, with a median of $7.0 million recorded in 2022.
  • Peak YoY movement for Non Operating Income: tumbled 76.2% in 2021, then soared 4088.48% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $519000.0 in 2021, then skyrocketed by 1248.75% to $7.0 million in 2022, then surged by 57.14% to $11.0 million in 2023, then increased by 18.18% to $13.0 million in 2024, then plummeted by 138.46% to -$5.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$5.0 million in Q4 2025, $7.0 million in Q3 2025, and $10.0 million in Q1 2025.